Calbryte 630

Calbryte™ 630 AM
20720 2x50 ug
EUR 262.8

Aat Bioquest Laboratories manufactures the calbryte 630 reagents distributed by Genprice. The Calbryte 630 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact AAT Bioquest. Other Calbryte products are available in stock. Specificity: Calbryte Category: 630

mFluor™ Yellow 630 SE
1 mg
EUR 60

mFluor™ Blue 630 SE
1 mg
EUR 318

mFluor™ Green 630 SE
1 mg
EUR 318

mFluor™ Yellow 630-streptavidin conjugate
100 ug
EUR 158.4

Cal-630™-Dextran Conjugate *MW 3,000*
1 mg
EUR 60

Cal-630™-Dextran Conjugate *MW 10,000*
1 mg
EUR 367.2

mFluor™ Yellow 630 Anti-human CD43 Antibody *HI161*
100 tests
EUR 245

Serum / Plasma information

Cal-630™ AM
20530 5x50 ug
EUR 367.2

Cal-630™ AM
20531 10x50 ug
EUR 471.6

Cal-630™ AM
20532 1 mg
EUR 784.8

hsa-miR-630 Primers
MPH01931 150 ul / 10 uM
EUR 145.2

mFluor™ Yellow 630 acid
1145 5 mg
EUR 60

Cal-630™, sodium salt
20535 5x50 ug
EUR 262.8

Cal-630™, potassium salt
20538 5x50 ug
EUR 262.8

mFluor™ Yellow 630 SE
1170 1 mg
EUR 60

Polyclonal NLRX1 Antibody (aa580-630)
APR02984G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NLRX1 (aa580-630). This antibody is tested and proven to work in the following applications:

hsa-miR-630 miRNA Inhibitor
MIH03280 2 x 5.0 nmol
EUR 211.2

hsa-miR-630 miRNA Antagomir
MNH03280 2 x 5.0 nmol
EUR 394.8

mFluor™ Blue 630 SE
1164 1 mg
EUR 318

mFluor™ Green 630 SE
1168 1 mg
EUR 318

Siglec 9 Recombinant Protein
91-630 0.05 mg
EUR 588.3
Description: Sialic acid-binding Ig-like lectin 9(Siglec 9) is expressed by peripheral blood leukocytes (neutrophils and monocytes but not eosinophils), and found in liver, fetal liver, bone marrow, placenta, spleen and in lower levels in skeletal muscle, fetal brain and so on. It is a putative adhesion molecule that mediates sialic-acid dependent binding to cells. It also binds to alpha-2,3- or alpha-2,6-linked sialic acid. The sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface.

HB-EGF Recombinant Protein
40-630 10 ug
EUR 311.1
Description: HB-EGF is an EGF-related growth factor that signals through the EGF receptor, and stimulates the proliferation of smooth muscle cells (SMC), fibroblasts, epithelial cells, and keratinocytes. HB-EGF is expressed in numerous cell types and tissues, including vascular endothelial cells, and vascular SMC, macrophages, skeletal muscle, keratinocytes, and certain tumor cells. The ability of HB-EGF to specifically bind heparin and heparin sulfate proteoglycans is distinct from other EGF-like molecules, and may be related to the enhanced mitogenic activity, relative to EGF, that HB-EGF exerts on smooth muscle cells. The human HB-EGF gene encodes a 208 amino acid transmembrane protein, which can be proteolytically cleaved to produce soluble HB-EGF. Recombinant Human HB-EGF is a 9.7 kDa protein containing 86 amino acid residues, corresponding to the extracellular EGF-like and heparin-binding domains of the full length HB-EGF protein.

IL-12 p40 Recombinant Protein
92-630 0.05 mg
EUR 651.3
Description: Interleukin-12 subunit beta (IL-12B) belongs to the type I cytokine receptor family. It contains 1 fibronectin type-III domain and 1 Ig-like C2-type domain. IL-12B is a cytokine that acts on T and natural killer cells, and has a broad array of biological activities. IL-12 is a disulfide-linked heterodimer composed of the 40 kD cytokine receptor encoded by IL12B and a 35 kD subunit encoded by IL12A. IL12 is expressed by activated macrophages that serve as an essential inducer of Th1 cells development. It has been found to be important for sustaining a sufficient number of memory/effector Th1 cells to mediate long-term protection to an intracellular pathogen.

PLAU Recombinant Protein
96-630 0.05 mg
EUR 682.8
Description: Urokinase - type plasminogen activator is also known as PLAU and UPA, a serine protease with an extremely limited substrate specificity, cleaving the sequence Cys – Pro – Gly - Arg560 - Val561 – Val – Gly – Gly – Cys in plasminogen to form plasmin. uPA is a potent marker of invasion and metastasis in a variety of human cancers associated with breast, stomach, colon, bladder, ovary, brain and endometrium.uPA and its receptor (uPAR) have been implicated in a broad spectrum of pathophysiological processes, including fibrinolysis, proteolysis, inflammation, atherogenesis and plaque destabilization, all of which are involved in the pathogenesis of MI (myocardial infarction).